← All stories
Markets
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.
Covered by 1 outlet
All coverage · 1 article